urologic oncology

Asieris Advances Biopharma Pipeline and CEVIRA Launch

SHANGHAI, China, Aug 28, 2026 Asieris Pharmaceuticals has released its 2026 Semi-Annual Report, highlighting progress in commercial operations, international...

By cGxPwire Editor
August 31, 2026

.Clinical

Hamlet BioPharma Advances Alpha1H into Phase 3 Trial

LUND, Sweden, June 17, 2026 Hamlet BioPharma AB has reached a major clinical development milestone with the successful completion...

By cGxPwire Editor
June 23, 2026

.Clinical

Hamlet BioPharma Expands Alpha1H Trial for Bladder Cancer

LUND, Sweden, June 22, 2026 Hamlet BioPharma AB has announced a significant expansion of its U.S. clinical development program...

By cGxPwire Editor
June 23, 2026

Bio-Pharma

INLEXZO Shows 74% One-Year Disease-Free Survival in High-Risk NMIBC

NEW BRUNSWICK, NJ — December 2025 — Johnson & Johnson announced new one-year results showing that its intravesical gemcitabine...

By cGxPwire Editor
December 8, 2025

We work Hard to get you posted with latest updates

Unwrap our new Directory

Asieris Advances Biopharma Pipeline and CEVIRA Launch

Hamlet BioPharma Advances Alpha1H into Phase 3 Trial

Hamlet BioPharma Expands Alpha1H Trial for Bladder Cancer

INLEXZO Shows 74% One-Year Disease-Free Survival in High-Risk NMIBC